studyfinds22h
23andMe reportedly faces bankruptcy — What will happen to everyone’s DNA samples?
A giant biotechnology company might be about to go bust. What will happen to the millions of people’s DNA it holds?
People are fleeing 23andMe. It's trickier than they realize.
Once a superpopular tool for people wanting to research their ancestry, genetic testing company 23andMe is floundering, with copious losses and a rock-bottom stock price. The heat on the South San ...
23andMe data breach class-action lawsuit: What it entails and what to know about $30M settlement
In 2023, 23andMe had a data breach the exposed millions of people ancestry data. The lawsuit that followed, has reached a $30 ...
Forbes7d
Did You Give Your DNA To 23andMe? Here’s Why You Might Regret It Soon
Amid financial challenges, DNA testing company 23andMe is reportedly exploring a potential sale, which could place the genetic data of over 15 million customers in the hands of new ownership.
USA Today11d
With 23andMe's future unclear, what will happen to users' data? Here's how to delete it
Americans curious about their ancestry likely paid for a DNA test through 23andMe. 23andMe is on the brink of a financial collapse. The company – founded in 2006 – is now considered ...
Gizmodo6d
There’s Never Been a Better Time to Delete Your 23andMe Data. Here’s How to Do It
23andMe, the troubled genomics company, has been in a downward spiral ever since it suffered a data breach last year. The company, which is headed by Sergei Brin’s ex-wife, Anne Wojcicki, has ...
Australian Broadcasting Corporation5d
23andMe is on the verge of bankruptcy. It may be too late to delete your genetic data
Popular genetic testing company 23andMe is facing bankruptcy and may sell the genetic data of its 15 million customers. Users have the option to delete their data, but the company can retain it ...
Fox2Now St. Louis1mon
23andMe directors resign as the CEO of the genetic-testing company seeks to take it private
NEW YORK (AP) — All of 23andMe’s independent directors resigned from its board this week, a rare move that marks the latest challenge for the genetic-testing company. The resignations follow ...